Wrong.
That was 2019.
We now know (this week) that the next payment from Grunenthal relates to a successful FDA approval, run and paid for by Mesoblast.
We can now safely assume that the above will be done IFF (THAT'S IF AND ONLY IF) FDA approval is given.
No, the FDA does not wave a magic wand over Europe and Latin America.
Why don't you just go back to being happy the share price has gone up? It's better suited to you?
Wrong.That was 2019.We now know (this week) that the next...
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.015(1.01%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $13.91M | 9.288M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 32769 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 20813 | 10 |
View Market Depth
| Last trade - 14.06pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |